(Q83403908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Young Wha Koh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hee Jin Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jong Won Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jun Kang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Gyungyub Gong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

11 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

794-800

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21317877%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.9

22 January 2020

exact match

0 references

cites work

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of A

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Metallographic in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021

Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.9

7 January 2021